IQVIA HOLDINGS INC (IQV)
US46266C1053 - Common Stock
Taking everything into account, IQV scores 5 out of 10 in our fundamental rating. IQV was compared to 59 industry peers in the Life Sciences Tools & Services industry. IQV has an excellent profitability rating, but there are concerns on its financial health. IQV is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IQV had positive earnings in the past year.
In the past year IQV had a positive cash flow from operations.
In the past 5 years IQV has always been profitable.
IQV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 5.11%, IQV is doing good in the industry, outperforming 77.97% of the companies in the same industry.
IQV's Return On Equity of 21.39% is amongst the best of the industry. IQV outperforms 94.92% of its industry peers.
IQV's Return On Invested Capital of 9.05% is amongst the best of the industry. IQV outperforms 84.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IQV is below the industry average of 10.68%.
The 3 year average ROIC (7.75%) for IQV is below the current ROIC(9.05%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.11% | ||
| ROE | 21.39% | ||
| ROIC | 9.05% |
ROA(3y)4.44%
ROA(5y)3.05%
ROE(3y)19.04%
ROE(5y)12.99%
ROIC(3y)7.75%
ROIC(5y)6.1%
1.3 Margins
IQV has a better Profit Margin (9.01%) than 79.66% of its industry peers.
IQV's Profit Margin has improved in the last couple of years.
The Operating Margin of IQV (13.90%) is better than 77.97% of its industry peers.
IQV's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 35.03%, IQV is doing worse than 64.41% of the companies in the same industry.
In the last couple of years the Gross Margin of IQV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.9% | ||
| PM (TTM) | 9.01% | ||
| GM | 35.03% |
OM growth 3Y25.9%
OM growth 5Y12.1%
PM growth 3Y54.53%
PM growth 5Y29.51%
GM growth 3Y0.96%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
IQV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
IQV has less shares outstanding than it did 1 year ago.
IQV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IQV has a worse debt to assets ratio.
2.2 Solvency
IQV has an Altman-Z score of 2.20. This is not the best score and indicates that IQV is in the grey zone with still only limited risk for bankruptcy at the moment.
IQV has a Altman-Z score (2.20) which is comparable to the rest of the industry.
IQV has a debt to FCF ratio of 8.33. This is a slightly negative value and a sign of low solvency as IQV would need 8.33 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 8.33, IQV is doing good in the industry, outperforming 62.71% of the companies in the same industry.
A Debt/Equity ratio of 2.02 is on the high side and indicates that IQV has dependencies on debt financing.
IQV has a Debt to Equity ratio of 2.02. This is amonst the worse of the industry: IQV underperforms 86.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.02 | ||
| Debt/FCF | 8.33 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.77
WACC11.76%
2.3 Liquidity
IQV has a Current Ratio of 0.88. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
IQV has a worse Current ratio (0.88) than 93.22% of its industry peers.
A Quick Ratio of 0.88 indicates that IQV may have some problems paying its short term obligations.
IQV has a worse Quick ratio (0.88) than 91.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.48% over the past year.
IQV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.97% yearly.
Looking at the last year, IQV shows a small growth in Revenue. The Revenue has grown by 3.97% in the last year.
IQV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.55% yearly.
EPS 1Y (TTM)1.48%
EPS 3Y16.72%
EPS 5Y12.97%
EPS Q2Q%3.67%
Revenue 1Y (TTM)3.97%
Revenue growth 3Y9.67%
Revenue growth 5Y7.55%
Sales Q2Q%2.33%
3.2 Future
IQV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.57% yearly.
The Revenue is expected to grow by 6.00% on average over the next years.
EPS Next Y9.59%
EPS Next 2Y11%
EPS Next 3Y11.7%
EPS Next 5Y12.57%
Revenue Next Year3.78%
Revenue Next 2Y5.42%
Revenue Next 3Y5.92%
Revenue Next 5Y6%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.66 indicates a rather expensive valuation of IQV.
96.61% of the companies in the same industry are more expensive than IQV, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IQV to the average of the S&P500 Index (28.39), we can say IQV is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.91, the valuation of IQV can be described as correct.
Based on the Price/Forward Earnings ratio, IQV is valued cheaper than 93.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 19.91, IQV is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.66 | ||
| Fwd PE | 16.91 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IQV indicates a rather cheap valuation: IQV is cheaper than 93.22% of the companies listed in the same industry.
89.83% of the companies in the same industry are more expensive than IQV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.87 | ||
| EV/EBITDA | 15.66 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IQV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)1.59
EPS Next 2Y11%
EPS Next 3Y11.7%
5. Dividend
5.1 Amount
No dividends for IQV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IQVIA HOLDINGS INC
NYSE:IQV (6/14/2024, 7:16:25 PM)
After market: 212.75 0 (0%)212.75
-1.21 (-0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.76B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.66 | ||
| Fwd PE | 16.91 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.15
PEG (5Y)1.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.11% | ||
| ROE | 21.39% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.9% | ||
| PM (TTM) | 9.01% | ||
| GM | 35.03% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)1.48%
EPS 3Y16.72%
EPS 5Y
EPS Q2Q%
EPS Next Y9.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.97%
Revenue growth 3Y9.67%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y